Boxer Capital, LLC’s Beone Medicines Ltd Position
Does Boxer Capital, LLC own Beone Medicines Ltd (ONC)? Not currently — the last reported position was 500.0K shares worth $112M in Q3 2024; the fund’s latest 13F (Q4 2024) no longer reports it.
Position Value
$112M
Q3 2024
Shares
500.0K
% of Portfolio
+5.51%
Quarters Held
24
position exited
Position History ONC
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q3 2024 | 500.0K | $112M | +5.51% |
| Q2 2024 | 500.0K | $71M | +3.76% |
| Q1 2024 | 500.0K | $78M | +3.86% |
| Q4 2023 | 500.0K | $90M | +4.49% |
| Q3 2023 | 500.0K | $90M | +4.79% |
| Q2 2023 | 500.0K | $89,150 | +4.13% |
| Q1 2023 | 500.0K | $107,765 | +5.29% |
| Q4 2022 | 500.0K | $110M | +5.80% |
| Q3 2022 | 500.0K | $67M | +3.79% |
| Q2 2022 | 500.0K | $81M | +5.13% |
| Q1 2022 | 500.0K | $94M | +4.85% |
| Q4 2021 | 500.0K | $135M | +5.26% |
| Q3 2021 | 764.2K | $277M | +9.69% |
| Q2 2021 | 764.2K | $262M | +9.25% |
| Q1 2021 | 764.2K | $266M | +9.02% |
| Q4 2020 | 1.11M | $288M | +9.25% |
| Q3 2020 | 1.11M | $319M | +11.03% |
| Q2 2020 | 925.0K | $174M | +7.66% |
| Q1 2020 | 925.0K | $114M | +7.76% |
| Q4 2019 | 925.0K | $153M | +8.67% |
| Q3 2019 | 925.0K | $113M | +8.21% |
| Q2 2019 | 900.0K | $112M | +9.59% |
| Q1 2019 | 900.0K | $119M | +13.74% |
| Q4 2018 | 900.0K | $126M | +15.60% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Boxer Capital, LLC’s full portfolio or all institutional holders of ONC.